Vanda Pharmaceuticals Inc. (VNDA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 293.17M | 347.26M | 367.5M | 394.92M | 407.91M | 438.89M | 432.39M | 439.18M | 439.43M | 432.95M | 536.57M | 533.5M |
| Cash & Short-Term Investments | 202.31M | 263.85M | 293.75M | 325.55M | 340.91M | 374.64M | 376.26M | 387.68M | 394.14M | 388.26M | 489.86M | 489.35M |
| Cash Only | 54.03M | 84.85M | 70.02M | 80.98M | 111.8M | 102.32M | 100.5M | 102.95M | 125.16M | 135.82M | 183.19M | 150.03M |
| Short-Term Investments | 148.28M | 179M | 223.73M | 244.57M | 229.11M | 272.33M | 275.76M | 284.72M | 268.98M | 252.44M | 306.67M | 339.32M |
| Accounts Receivable | 56.88M | 54.58M | 50.54M | 44.99M | 44.6M | 47.1M | 42.75M | 41.86M | 36.71M | 34.16M | 29.27M | 33.62M |
| Days Sales Outstanding | 96.98 | 84.51 | 78.11 | 77.52 | 82.47 | 77.72 | 81.69 | 70.83 | 67.94 | 64.45 | 74.54 | 57.43 |
| Inventory | 1.7M | 1.85M | 2.04M | 2.17M | 1.92M | 1.73M | 1.61M | 1.47M | 1.5M | 1.36M | 1.01M | 1.08M |
| Days Inventory Outstanding | - | 46.73 | 65.57 | 41.49 | 46.64 | 59.32 | 55.59 | 30.17 | 23.86 | 31.42 | 31.33 | 28.41 |
| Other Current Assets | 32.28M | 26.98M | 21.16M | 22.21M | 20.48M | 15.42M | 11.76M | 8.17M | 7.07M | 9.17M | 16.44M | 9.45M |
| Total Non-Current Assets | 140.36M | 141.69M | 233.64M | 229.82M | 224.03M | 217.31M | 212.73M | 212.19M | 213.26M | 215.49M | 105.03M | 108.18M |
| Property, Plant & Equipment | 14.06M | 13.51M | 11.9M | 12.47M | 12.47M | 12.68M | 8.19M | 8.68M | 9.05M | 9.14M | 9.56M | 9.95M |
| Fixed Asset Turnover | 3.75x | 4.50x | 4.62x | 4.22x | 3.98x | 5.10x | 5.65x | 5.69x | 5.22x | 4.84x | 3.98x | 4.52x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 115.1M | 117.09M | 108.84M | 110.59M | 112.34M | 114.1M | 115.85M | 117.6M | 119.35M | 121.37M | 17.43M | 17.81M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 469K | 469K | 0 | 0 | 0 |
| Other Non-Current Assets | 11.19M | 11.08M | 9.83M | 9.62M | 10.06M | 9.1M | 9.32M | 8.89M | 9.05M | 9.98M | 10.28M | 9.95M |
| Total Assets | 433.52M | 488.95M | 601.14M | 624.75M | 631.94M | 656.2M | 645.12M | 651.37M | 652.68M | 648.44M | 641.61M | 641.68M |
| Asset Turnover | 0.11x | 0.10x | 0.09x | 0.08x | 0.08x | 0.08x | 0.07x | 0.08x | 0.07x | 0.07x | 0.06x | 0.07x |
| Asset Growth % | -31.4% | -25.49% | -6.82% | -4.09% | -3.18% | 1.2% | 0.55% | 1.51% | 1.26% | 2.24% | 3.19% | 5.35% |
| Total Current Liabilities | 135.58M | 145.16M | 117.87M | 121.49M | 103.92M | 99.98M | 89.09M | 93.79M | 93.34M | 87.7M | 84.84M | 87.4M |
| Accounts Payable | 0 | 4.94M | 3.14M | 2.18M | 5.99M | 3.5M | 5.81M | 3.78M | 6.58M | 7.14M | 3.49M | 2.17M |
| Days Payables Outstanding | - | 96.97 | 82.86 | 82.86 | 121.26 | 165.3 | 172.84 | 105.05 | 114.41 | 141.36 | 84.97 | 77.63 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.43M | 2.41M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 135.58M | 87.19M | 79M | 71.27M | 62.44M | 69.36M | 56.47M | 83.04M | 81.97M | 69.33M | 37.95M | 39.45M |
| Current Ratio | 2.16x | 2.39x | 3.12x | 3.25x | 3.93x | 4.39x | 4.85x | 4.68x | 4.71x | 4.94x | 6.32x | 6.10x |
| Quick Ratio | 2.15x | 2.38x | 3.10x | 3.23x | 3.91x | 4.37x | 4.84x | 4.67x | 4.69x | 4.92x | 6.31x | 6.09x |
| Cash Conversion Cycle | - | 34.28 | 60.83 | 36.15 | 7.84 | -28.26 | -35.56 | -4.05 | -22.61 | -45.5 | 20.89 | 8.21 |
| Total Non-Current Liabilities | 17.18M | 16.6M | 17.27M | 16.93M | 16.6M | 17.68M | 14.8M | 15.06M | 15.34M | 15.83M | 13.67M | 14.39M |
| Long-Term Debt | 7.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 7.07M | 6.23M | 6.96M | 7.35M | 8.09M | 5.49M | 6M | 6.51M | 7.01M | 7.47M | 7.94M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 10.13M | 9.53M | 11.04M | 9.97M | 9.24M | 9.59M | 9.32M | 9.06M | 8.83M | 8.83M | 6.2M | 6.45M |
| Total Liabilities | 152.76M | 161.76M | 135.14M | 138.42M | 120.52M | 117.66M | 103.89M | 108.86M | 108.69M | 103.53M | 98.5M | 101.78M |
| Total Debt | 7.05M | 12.62M | 10.91M | 11.64M | 11.74M | 12.36M | 7.94M | 8.43M | 8.92M | 9.4M | 9.85M | 10.31M |
| Net Debt | -46.98M | -72.23M | -59.11M | -69.34M | -100.05M | -89.96M | -92.56M | -94.52M | -116.23M | -126.42M | -173.34M | -139.72M |
| Debt / Equity | 0.03x | 0.04x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 280.76M | 327.19M | 466M | 486.33M | 511.42M | 538.55M | 541.22M | 542.52M | 544M | 544.91M | 543.1M | 539.9M |
| Equity Growth % | -45.1% | -39.25% | -13.9% | -10.36% | -5.99% | -1.17% | -0.35% | 0.48% | 1.54% | 3.36% | 5.32% | 6.16% |
| Book Value per Share | 4.72 | 5.54 | 7.92 | 8.24 | 8.74 | 9.24 | 9.29 | 9.32 | 9.42 | 9.47 | 9.43 | 9.38 |
| Total Shareholders' Equity | 280.76M | 327.19M | 466M | 486.33M | 511.42M | 538.55M | 541.22M | 542.52M | 544M | 544.91M | 543.1M | 539.9M |
| Common Stock | 60K | 59K | 59K | 59K | 59K | 58K | 58K | 58K | 58K | 58K | 58K | 57K |
| Retained Earnings | -443.33M | -394.77M | -253.58M | -230.99M | -203.79M | -174.29M | -169.38M | -164.06M | -159.54M | -155.39M | -152.99M | -153.13M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 212K | 629K | 540K | 396K | 383K | 74K | 702K | -330K | -383K | -30K | -967K | -865K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |